Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disruptive Behaviour in Children”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02712996
What this trial is testing

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children

Who this might be right for
Traumatic Brain InjuryAttention Deficit Disorder
Vanderbilt University 20
Post-approval studies (Phase 4)UnknownNCT00252278
What this trial is testing

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Who this might be right for
Attention-Deficit/Hyperactivity Disorder (ADHD)Insomnia
Rhode Island Hospital 36
Not applicableStudy completedNCT04707040
What this trial is testing

Neurocognitive Exercise Program for Children With Attention Deficit and Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
Dokuz Eylul University 14
Not applicableLooking for participantsNCT06369714
What this trial is testing

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

Who this might be right for
Attention Deficit Disorder With HyperactivityExecutive Function Disorder
Lei Lei, MD 210
Large-scale testing (Phase 3)Ended earlyNCT01340690
What this trial is testing

Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder

Who this might be right for
ADHD
Johannes Gutenberg University Mainz 284
Not applicableStudy completedNCT06996678
What this trial is testing

Effect of Virtual Reality on Cognitive Skills

Who this might be right for
Virtual Reality
Hacettepe University 14
Large-scale testing (Phase 3)Study completedNCT00857220
What this trial is testing

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Who this might be right for
InsomniaAttention Deficit Hyperactivity Disorder
Sumitomo Pharma America, Inc. 304
Not applicableLooking for participantsNCT06221358
What this trial is testing

Pharmacogenomics of Stimulant Treatment Response

Who this might be right for
Attention-Deficit/ Hyperactivity Disorder (ADHD)
University of Calgary 400
Large-scale testing (Phase 3)Study completedNCT00192023
What this trial is testing

An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).

Who this might be right for
Attention Deficit Hyperactivity DisorderOppositional Defiant Disorder
Eli Lilly and Company 139
Not applicableUnknownNCT02973061
What this trial is testing

The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents

Who this might be right for
Growth Hormone DeficiencyAttention Deficit DisorderIdiopathic Short Stature
Assaf-Harofeh Medical Center 100
Large-scale testing (Phase 3)Study completedNCT00151983
What this trial is testing

Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Noven Therapeutics 175
Large-scale testing (Phase 3)Study completedNCT01106430
What this trial is testing

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Shire 267
Not applicableLooking for participantsNCT07327775
What this trial is testing

Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder

Who this might be right for
Fibromyalgia SyndromeDisease BurdenAttention-Deficit/Hyperactivity Disorder
Sultan 1. Murat State Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT03325894
What this trial is testing

Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
Shire 141
Post-approval studies (Phase 4)Study completedNCT00593112
What this trial is testing

Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate

Who this might be right for
ADHD
Massachusetts General Hospital 39
Not applicableLooking for participantsNCT06241300
What this trial is testing

Executive Function and Parenting in Childhood

Who this might be right for
Disruptive Behavior Disorder, Childhood OnsetDisruptive BehaviorExecutive Function
University of Illinois at Chicago 180
Not applicableStudy completedNCT05906485
What this trial is testing

FNIRS Neurofeedback Training Using Virtual Reality in Children With ADHD

Who this might be right for
ADHD
The University of Hong Kong 138
Not applicableStudy completedNCT05301933
What this trial is testing

Telehealth BPT in DBP Practice

Who this might be right for
ADHD
NYU Langone Health 13
Not applicableEnrolling By InvitationNCT07216638
What this trial is testing

Pediatric Behavioral Health Integrated Care: Indiana Statewide Strategic Plan to Address the Growing Mental Health Crisis

Who this might be right for
Implementation ResearchDepressive DisorderANXIETY DISORDERS (or Anxiety and Phobic Neuroses)+2 more
Indiana University 575
Large-scale testing (Phase 3)Study completedNCT00266552
What this trial is testing

The Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation

Who this might be right for
Conduct DisorderDisruptive Behavior DisorderOppositional Defiant Disorder
Janssen Pharmaceutica N.V., Belgium 118
Next Page